This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe
Home    About    Scholarships    Meetings    Publications    Resources    Join ASCLS June. 28, 2011
ASCLS eNewsBytes
June. 28, 2011
ASCLS Quick Links >   Home    About    Scholarships    Meetings    Publications    Resources


hs-CRP: What is proven and unproven?
Medscape    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A recent large meta-analysis of genome-wide association studies from 15 cohort studies comprising 66,185 subjects and a replication sample of 16,540 subjects identified 18 gene loci associated with C-reactive protein (CRP) levels. These 18 gene loci were mostly associated with immune response and metabolic regulatory pathways involved in the regulation of chronic inflammation. More



Saxagliptin effective with less hypoglycemia than glipizide
Medscape    Share    Share on FacebookTwitterShare on LinkedinE-mail
article
Saxagliptin demonstrated reductions in glycosylated hemoglobin (HbA1c) and fasting plasma glucose that were similar to those seen with the sulfonylurea drug glipizide, when both were added to metformin, but it had a lower risk for hypoglycemia and led to more weight loss in patients with type 2 diabetes, according to a long-term study. More

In search of the memory molecule, researchers discover key protein complex
ScienceDaily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Have a tough time remembering where you put your keys, learning a new language or recalling names at a cocktail party? New research from the Lisman Laboratory at Brandeis University points to a molecule that is central to the process by which memories are stored in the brain. More



Qualiris by Stago

Qualiris by Stago is a Web-based External Quality Assessment program used to provide enhanced confidence for your hemostasis testing. Qualiris provides peer-group, result comparisons from a global to a local level. Stago's dedicated experts are available 24/7 to help interpret your results. For more information on Quadfsliris visit www.stago-us.com.


Pharmacogenomics of warfarin: Clinical implications
Medscape    Share    Share on FacebookTwitterShare on LinkedinE-mail article
There is currently a wealth of data surrounding genetic polymorphisms in 2 genes, CYP2C9 and VKORC1, and how these specific polymorphisms affect variation in warfarin dose requirements, international normalized ratio control during warfarin initiation, and, for certain variants, bleeding outcomes in patients treated with warfarin. The strength of this evidence prompted the U.S. Food and Drug Administration (FDA) to update the drug label for warfarin in 2007 and then again in January 2010 with recommendations for initiation dose modifications in carriers of the specific CYP2C9 and VKORC1 variants. More

Human cells fitted with synthetic signaling cascade
ScienceDaily    Share    Share on FacebookTwitterShare on LinkedinE-mail
article
Researchers from ETH Zurich have fitted human cells with a synthetic signaling cascade that can be used to switch on and regulate genes via blue light. This "gene light switch" makes interesting therapies possible, which could be used to treat type 2 diabetes, for instance. More



Specialists in Bone, Growth, Cartilage, Hypertension & Automation

IDS manufactures and markets specialist Immunoassays for diagnostic and research laboratory testing. These include fully automated and manual assays.


Morphological heterogeneity of oral salivary gland carcinomas
International Journal of Clinical and Experimental Pathology    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers analyzed 41 oral salivary gland carcinomas from consecutive 290 salivary gland carcinoma database (14 percent) with emphasis on the histological spectrum and clinical outcome of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma. The cohort included 14 ACCs, 14 mucoepidermoid carcinomas, eight PLGAs, three adenocarcinomas, not otherwise specified and two acinic cell carcinomas. More

Doctors make breakthrough in repairing genetic defects
The Guardian    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Doctors have treated a life-threatening blood disease by repairing flaws in the genetic code of a living animal, the first time such an ambitious feat has been achieved. The work raises the prospect of powerful new therapies that can target and repair the genetic defects behind a wide range of human diseases that cannot be tackled with modern medicines. More

A breath of fresh air in diagnostics

Providing the accurate, dependable allergy, urinalysis and auto-immune results you require. Delivering the cost-effective test results you value.
MORE


'Lean gene' ups risk of heart disease and diabetes
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Being slim may not always lead to a lower risk of heart disease and diabetes, scientists said after they identified a gene linked both to having a lean body and to a higher risk of metabolic diseases. More

Bile duct cancer from liver fluke infection
Medscape    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Infection with the parasitic liver fluke Opisthorchis viverrini does not always lead to bile duct cancer, but nearly all cases of cholangiocarcinoma develop in individuals with this infection. Hence, the liver flukes are officially classified by the World Health Organization as Group 1 carcinogens. More



Almost 2.8 million receive HIV tests in CDC program
Medscape    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A three-year program to expand access to HIV testing has diagnosed 18,432 individuals in high-risk areas who were previously unaware of their HIV status, the Centers for Disease Control and Prevention (CDC) announced recently. The $111 million program provided almost 2.8 million HIV tests; the CDC provided funds to 25 local health departments in areas with high HIV infection rates. More

At Phadia®, we see things differently.

See what we see. For cutting-edge testing technologies for allergic and autoimmune diseases… Look no further than Phadia. Contact us today at 800.346.4364 or www.phadia.us.


Woman's skin cells used in Long QT Syndrome research
Wisconsin State Journal    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A skin sample from Helen Eckert, transformed into a colony of heart cells in a University of Wisconson-Madison lab, could give scientists clues to what causes Long QT Syndrome, a genetic heart disease. Eckert, 69, from Lake Mills, Wis., has the condition that causes an irregular heartbeat and can lead to sudden death. She was the first of three patients with the condition who donated skin cells for stem cell research on campus. More
Triturus - True Open Flexibility
As a leader in fully automated immunoassay testing systems, Grifols USA Diagnostic Division’s premier product, the TRITURUS® ELISA System is an open, fully automated, multi-test and multi-batch immunoassay system. Grifols USA is a major distributor of quality IVD ELISA tests for Infectious Disease, Autoimmune Diseases and many other disease states. Grifols’ Diagnostic products take the complexity out of clinical diagnostic testing.

Contact us at 1-800-379-0957.
CellaVision Automates and Standardizes the Manual Differential

CellaVision introduces CellAtlas®, the perfect way to learn the basics of hematology cell morphology. This App for the Apple iPhone and iPod Touch compliments our digital cell morphology portfolio, and is an educational tool to assist in the recognition and classification of blood cells, by utilizing mini-lectures and cell quizzes.
More
Trust in Cleveland Clinic Laboratories
Cleveland Clinic Laboratories is a full-service, national reference lab dedicated to providing world class care. We have a dedicated staff of more than 1,300 employees, including board-certified subspecialty pathologists, PhDs, technologists, technicians, and support personnel. Cleveland Clinic Laboratories is proud to serve hospitals, outpatient facilities and physician offices worldwide. For more information, please visit clevelandcliniclabs.com.
This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here.

Did someone forward this edition to you? Subscribe here - it's free!

Advertise

Colby Horton, Vice President of Publishing
469.420.2601

Download Media Kit

To contribute news to the ASCLS eNewsBytes, contact Yvette Craig, Senior Content Editor
469.420.2641.

Recent Issues

  • June 21, 2011
  • June 14, 2011
  • June 7, 2011
  • May 31, 2011
  • Dedicated - Fisher Healthcare - May 2011
  •  RSS Feed
    Most popular articles